Doping. High-tech cheating in sport

Publikationstyp:
Zeitschriftenaufsatz
Metadaten:
Autoren
  • H Striegel
  • P Simon
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000253318700010&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.1007/s00108-007-1842-9
eISSN
1432-1289
Externe Identifier
  • Clarivate Analytics Document Solution ID: 264VO
  • PubMed Identifier: 17426943
ISSN
0020-9554
Ausgabe der Veröffentlichung
7
Zeitschrift
INTERNIST
Schlüsselwörter
  • doping
  • gene doping
  • anabolic androgenic steroids
  • growth hormones
  • erythropoietin
Paginierung
737 - 742
Datum der Veröffentlichung
2007
Status
Published
Titel
Doping. High-tech cheating in sport
Sub types
  • Article
Ausgabe der Zeitschrift
48

Datenquelle: Web of Science (Lite)

Andere Metadatenquellen:
Autoren
  • H Striegel
  • P Simon
DOI
10.1007/s00108-007-1842-9
eISSN
1432-1289
ISSN
0020-9554
Ausgabe der Veröffentlichung
7
Zeitschrift
Der Internist
Sprache
de
Online publication date
2007
Paginierung
737 - 742
Datum der Veröffentlichung
2007
Status
Published
Herausgeber
Springer Science and Business Media LLC
Herausgeber URL
http://dx.doi.org/10.1007/s00108-007-1842-9
Datum der Datenerfassung
2020
Titel
Doping
Ausgabe der Zeitschrift
48

Datenquelle: Crossref

Abstract
Today, doping is no longer limited to the classical drugs with well known effects and side effects. Older generation anabolic steroids are used mainly in fitness and recreational sports. In contrast, due to doping tests, substances used in competitive sports include peptide hormones, medications not yet approved, and even specially developed drugs, such as designer steroids. Of the peptide hormones, particularly growth hormones (human growth hormone), erythropoietin and generics, insulin, and presumably insulin-like growth factor 1 are used. Substance groups potentially relevant for doping are selective androgen receptor modulators and gene therapy drugs. For most of these, there is no knowledge about side effects in healthy individuals, and no adequate doping tests. Therefore, anti-doping measures cannot rely solely on the continual improvement of doping analyses, but should include increased measures for doping prevention. Not only sports organizations, but also governmental agencies should be involved in developing and implementing these measures.
Addresses
  • Abteilung Sportmedizin, Medizinische Universitätsklinik Tübingen. heiko.striegel@med.uni-tuebingen.de
Autoren
  • H Striegel
  • P Simon
DOI
10.1007/s00108-007-1842-9
eISSN
1432-1289
Externe Identifier
  • PubMed Identifier: 17426943
Open access
false
ISSN
0020-9554
Ausgabe der Veröffentlichung
7
Zeitschrift
Der Internist
Schlüsselwörter
  • Humans
  • Cross-Sectional Studies
  • Substance Abuse Detection
  • Forecasting
  • Drug and Narcotic Control
  • Doping in Sports
  • Germany
  • Genetic Therapy
  • Illicit Drugs
Sprache
ger
Medium
Print
Paginierung
737 - 742
Datum der Veröffentlichung
2007
Status
Published
Datum der Datenerfassung
2007
Titel
[Doping. High-tech cheating in sport].
Sub types
  • Review
  • Journal Article
Ausgabe der Zeitschrift
48

Datenquelle: Europe PubMed Central

Abstract
Today, doping is no longer limited to the classical drugs with well known effects and side effects. Older generation anabolic steroids are used mainly in fitness and recreational sports. In contrast, due to doping tests, substances used in competitive sports include peptide hormones, medications not yet approved, and even specially developed drugs, such as designer steroids. Of the peptide hormones, particularly growth hormones (human growth hormone), erythropoietin and generics, insulin, and presumably insulin-like growth factor 1 are used. Substance groups potentially relevant for doping are selective androgen receptor modulators and gene therapy drugs. For most of these, there is no knowledge about side effects in healthy individuals, and no adequate doping tests. Therefore, anti-doping measures cannot rely solely on the continual improvement of doping analyses, but should include increased measures for doping prevention. Not only sports organizations, but also governmental agencies should be involved in developing and implementing these measures.
Autoren
  • H Striegel
  • P Simon
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/17426943
DOI
10.1007/s00108-007-1842-9
ISSN
0020-9554
Ausgabe der Veröffentlichung
7
Zeitschrift
Internist (Berl)
Schlüsselwörter
  • Cross-Sectional Studies
  • Doping in Sports
  • Drug and Narcotic Control
  • Forecasting
  • Genetic Therapy
  • Germany
  • Humans
  • Illicit Drugs
  • Substance Abuse Detection
Sprache
ger
Country
Germany
Paginierung
737 - 742
Datum der Veröffentlichung
2007
Status
Published
Datum, an dem der Datensatz öffentlich gemacht wurde
2008
Titel
[Doping. High-tech cheating in sport].
Sub types
  • Journal Article
  • Review
Ausgabe der Zeitschrift
48

Datenquelle: PubMed

Beziehungen:
Eigentum von

Werkzeuge